Lung Cancer Considered

Release Date

All Episodes

Lung Cancer Considered in Portuguese: Junior Faculty Perspective

As part of IASLC’s Lung Cancer Considered World Language Series, guest host Dr. Maria Cecilia Mathias leads a discussion in Portuguese about the junior faculty perspective with Dr. Maria Thereza Starling and Dr. Paula Duarte.

. 44min 35sec

Lung Cancer Considered: Role of General Media in Lung Cancer Research

In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by CNN Medical Correspondent Meg Tirrell and WTOP reporter Neal Augenstein to discuss the role of the media in lung cancer awareness and perception. Traditional media, including television and radio, do muc ... Show more

. 31min 28sec

Lung Cancer Considered -- Immunotherapy Toxicity: Myths & Pearls

Since the first immunotherapy agent for lung cancer was approved in 2015, this class of drugs has captured the imagination and the narrative for the treatment of driver negative lung cancer. Immunotherapy is now the standard of care for most patients with lung cancer in some form ... Show more

. 18min 48sec

Lung Cancer Considered: A New Shot at Progress: Amivantamab Goes SubQ

The FDA has approved subcutaneous amivantamab. Join host Dr. Narjust Florez and guests, Dr. Natasha Leighl and Dr. Federico Cappuzzo, as they explore the science and convenience factor, as well as what this shift means for patients, clinicians, and oncology practice.

. 35min 43sec

Lung Cancer Considered at the ASCO IASLC 2025 North American Conference on Lung Cancer

In this special episode of Lung Cancer Considered, Dr. Narjust Florez and Dr. Stephen Liu discuss highlights from the IASLC | ASCO 2025 North America Conference on Lung Cancer. Dr. Igor Odintsov discusses updates in diagnostic pathology, including the integration of next-gen sequ ... Show more

. 37min 59sec